Marie-Claude Bourgeois-Daigneault
7PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 19, 2025
Oncolytic VSV-IL-2 has enhanced anticancer vaccination adjuvant abilities.Victor Mullins-Dansereau, Marie-Lou Myre, Angelina Bardoul
|Jan 08, 2025
The Small GTPase Ran Increases Sensitivity of Ovarian Cancer Cells to Oncolytic Vesicular Stomatitis Virus.Karen Geoffroy, Mélissa Viens, Emma Mary Kalin
|Jun 13, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.Jonathan J Hodgins, John Abou-Hamad, Colin Edward O'Dwyer
|May 12, 2021
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination.D G Roy, K Geoffroy, M Marguerie
|Oct 25, 2019
Pre-surgical oncolytic virotherapy improves breast cancer outcomes.Victor Mullins-Dansereau, Grégory Petrazzo, Karen Geoffroy
|Jan 05, 2018
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.Marie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Amelia Sadie Aitken
Pageof 2
Frequent Collaborators
3 joint publications
Dominic Guy Roy
3 joint publications
John Cameron Bell
2 joint publications
Karen Geoffroy
1 joint publications
Oliver Varette
1 joint publications
Theresa Falls
1 joint publications
Adrian Pelin
1 joint publications
Brian Dennis Lichty
1 joint publications
Guy Ungerechts
1 joint publications
Jean-Simon Diallo
1 joint publications
Jonathan J Hodgins
